Matthew Ross Boyd
CIK: 0002077001
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ENGN
enGene Holdings Inc.
Officer
Discretionary Trading P&L
Holdings
About Boyd Matthew Ross
Boyd Matthew Ross (SEC CIK 0002077001) files insider reports with the SEC as Chief Regulatory Officer of enGene Holdings Inc. (ENGN).
Signal8 holds 3 ownership filings by Boyd Matthew Ross (1 Form 3, 2 Form 4), filed between Jul 14, 2025 and Feb 3, 2026. Those filings report 2 transactions, from Jul 8, 2025 to Jan 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Boyd Matthew Ross's filings is in SAINT-LAURENT, A8.
Recent filings by Boyd Matthew Ross
Other insiders filing for enGene Holdings Inc. (ENGN)
- Grossman William, Interim Chief Medical Officer
- Chinoporos Constantine, Interim Chief Business Officer
- Richton Kathleen P., SVP, Finance and Treasurer
- Astley-Sparke Philip, Director
- BRUNK GERALD A, Director
- Glickman Richard M, Director